Graphene Quantum Dots in Neurodegeneration: Protein Aggregation and the Microglial State as Therapeutic Targets
Open Access
- 15 September 2026
- journal article
- review article
- Published by MDPI AG in Nanomaterials
- Vol. 16 (18) , 1158
Abstract
Graphene quantum dots (GQDs) constitute the zero-dimensional family of carbon nanomaterials, combining efficient penetration of the blood–brain barrier (BBB) with precisely controllable surface chemistry, and have drawn attention as theragnostic platforms that carry both diagnosis and therapy in a single particle. Although various neurodegenerative diseases each arise from a different causal protein, they converge on shared pathology: aberrant accumulation of neuronal proteins and chronic neuroinflammation driven by pathological activation of glial cells such as microglia and astrocytes. GQDs modulate aggregation through monomer capture that delays nucleation, the blockade of growing fibril tips, and the penetration and disassembly of mature fibrils, all of which have been verified against various protein aggregation models. Beyond aggregation control, heteroatom doping and surface functionalization design allow GQDs to scavenge reactive oxygen species (ROS) and adjust autophagic pathways, attenuating markers of pathological microglial activation. Tunable emission simultaneously enables imaging of pathological burden and high-sensitivity detection of fluid biomarkers, supporting integration of therapeutic and diagnostic functions. GQD bioactivity, however, is inherently double-edged: depending on composition and concentration, the same materials can trigger mitochondrial oxidative stress and ferroptosis rather than exerting antioxidant action, as observed in microglia and macrophages. Therefore, key challenges remain separating anti-inflammatory efficacy from toxicity through precise surface functionalization, ensuring batch-to-batch reproducibility, establishing standardized physicochemical reporting, and quantitatively delineating the therapeutic window.Keywords
Funding Information
- Dong-A University
This publication has 123 references indexed in Scilit:
- N‐Amino Peptide–Graphene Quantum Dot Loaded Small Extracellular Vesicles for Targeted Therapy of TauopathiesAdvanced NanoBiomed Research, 2025
- From Pristine to Heteroatom‐Doped Graphene Quantum Dots: An Essential Review and Prospects for Future ResearchSmall, 2023
- Graphene quantum dots: synthesis, properties, and applications to the development of optical and electrochemical sensors for chemical sensingMicrochimica Acta, 2022
- Synthesis, Applications, and Prospects of Graphene Quantum Dots: A Comprehensive ReviewSmall, 2021
- Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s diseaseActa Neuropathologica, 2021
- APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer’s diseaseActa Neuropathologica, 2020
- Graphene Quantum Dots and Their Applications in Bioimaging, Biosensing, and TherapyAdvanced Materials, 2019
- Untangling alpha synuclein fibrils by graphene quantum dotsMovement Disorders, 2018
- Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological DiseasesAdvanced Materials, 2018
- Hydrothermal Route for Cutting Graphene Sheets into Blue‐Luminescent Graphene Quantum DotsAdvanced Materials, 2010